NASDAQ:PETS - Nasdaq - US7163821066 - Common Stock - Currency: USD
NASDAQ:PETS (4/21/2025, 11:59:14 AM)
3.17
+0.08 (+2.59%)
The current stock price of PETS is 3.17 USD. In the past month the price decreased by -23.51%. In the past year, price decreased by -24.82%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TSCO | TRACTOR SUPPLY COMPANY | 24.2 | 26.25B | ||
ULTA | ULTA BEAUTY INC | 14.18 | 16.30B | ||
DKS | DICK'S SPORTING GOODS INC | 12.57 | 14.10B | ||
CHWY | CHEWY INC - CLASS A | 130.65 | 14.05B | ||
BBWI | BATH & BODY WORKS INC | 8.18 | 5.84B | ||
FIVE | FIVE BELOW | 13.01 | 3.61B | ||
ASO | ACADEMY SPORTS & OUTDOORS IN | 6.03 | 2.44B | ||
SIG | SIGNET JEWELERS LTD | 5.74 | 2.27B | ||
WRBY | WARBY PARKER INC-CLASS A | 53.04 | 1.67B | ||
WINA | WINMARK CORP | 31.72 | 1.25B | ||
UPBD | UPBOUND GROUP INC | 5.17 | 1.14B | ||
WOOF | PETCO HEALTH AND WELLNESS CO | N/A | 941.92M |
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 287 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS INC
420 South Congress Avenue
Delray Beach FLORIDA 33445 US
CEO: Menderes Akdag
Employees: 287
Company Website: https://www.1800petmeds.com/
Investor Relations: https://www.1800petmeds.com/who-we-are/who-we-are-investors.html
Phone: 15614264444
The current stock price of PETS is 3.17 USD. The price increased by 2.59% in the last trading session.
The exchange symbol of PETMED EXPRESS INC is PETS and it is listed on the Nasdaq exchange.
PETS stock is listed on the Nasdaq exchange.
7 analysts have analysed PETS and the average price target is 3.83 USD. This implies a price increase of 20.66% is expected in the next year compared to the current price of 3.17. Check the PETMED EXPRESS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PETMED EXPRESS INC (PETS) has a market capitalization of 65.49M USD. This makes PETS a Micro Cap stock.
PETMED EXPRESS INC (PETS) currently has 287 employees.
PETMED EXPRESS INC (PETS) has a support level at 3.03 and a resistance level at 3.99. Check the full technical report for a detailed analysis of PETS support and resistance levels.
The Revenue of PETMED EXPRESS INC (PETS) is expected to decline by -17.16% in the next year. Check the estimates tab for more information on the PETS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PETS does not pay a dividend.
PETMED EXPRESS INC (PETS) will report earnings on 2025-05-12, after the market close.
The PE ratio for PETMED EXPRESS INC (PETS) is 317. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 3.17 USD. Check the full fundamental report for a full analysis of the valuation metrics for PETS.
The outstanding short interest for PETMED EXPRESS INC (PETS) is 9.98% of its float. Check the ownership tab for more information on the PETS short interest.
ChartMill assigns a fundamental rating of 4 / 10 to PETS. No worries on liquidiy or solvency for PETS as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months PETS reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS increased by 102.56% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.14% | ||
ROA | 0.25% | ||
ROE | 0.37% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to PETS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 153.62% and a revenue growth -17.16% for PETS